Table 1 Demographics of subjects used
From: Mitochondrial tRNA methylation in Alzheimer’s disease and progressive supranuclear palsy
Diagnosis | Sex | Age at Death | APOE | ||
|---|---|---|---|---|---|
e2 | e3 | e4 | |||
NC (n = 74) | Male (n = 40) | 80.93 ± 8.15 | 7.43% | 86.40% | 6.08% |
Female (n = 34) | 85.15 ± 6.76 | ||||
AD (n = 82) | Male (n = 34) | 81.68 ± 8.17 | 2.44% | 68.30% | 29.30% |
Female (n = 48) | 83.21 ± 7.19 | ||||
PSP (n = 83) | Male (n = 51) | 74.22 ± 6.94 | 9.04% | 82.53% | 8.43% |
Female (n = 32) | 73.65 ± 5.99 | ||||
PA (n = 27) | Male (n = 11) | 85.18 ± 3.74 | 7.41% | 75.92% | 16.67% |
Female (n = 16) | 84.06 ± 4.65 | ||||